Your browser doesn't support javascript.
Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.
Raichle, Claudia; Borgmann, Stefan; Bausewein, Claudia; Rieg, Siegbert; Jakob, Carolin E M; Simon, Steffen T; Tometten, Lukas; Vehreschild, Jörg Janne; Leisse, Charlotte; Erber, Johanna; Stecher, Melanie; Pauli, Berenike; Rüthrich, Maria Madeleine; Pilgram, Lisa; Hanses, Frank; Isberner, Nora; Hower, Martin; Degenhardt, Christian; Hertenstein, Bernd; Vehreschild, Maria J G T; Römmele, Christoph; Jung, Norma.
  • Raichle C; Department of Geriatric and Palliative Medicine, Tropenklinik Paul-Lechler-Krankenhaus, Tübingen, Germany.
  • Borgmann S; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany.
  • Bausewein C; Department of Palliative Medicine, LMU Hospital, München, Germany.
  • Rieg S; Division of Infectious Diseases, Department of Medicine II, Medical Centre-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Jakob CEM; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Simon ST; Department of Palliative Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Tometten L; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Vehreschild JJ; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Leisse C; Center for Internal Medicine, Medical Department 2, Hematology/Oncology and Infectious Diseases, University Hospital of Frankfurt, Frankfurt, Germany.
  • Erber J; German Centre for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Stecher M; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Pauli B; Department of Internal Medicine II, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany.
  • Rüthrich MM; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Pilgram L; German Centre for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Hanses F; Department of Palliative Medicine, Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Isberner N; Department of Internal Medicine II, Hematology and Medical Oncology, University Hospital Jena, Jena, Germany.
  • Hower M; Center for Internal Medicine, Medical Department 2, Hematology/Oncology and Infectious Diseases, University Hospital of Frankfurt, Frankfurt, Germany.
  • Degenhardt C; Emergency Department, University Hospital Regensburg, Regensburg, Germany.
  • Hertenstein B; Department for Infectious Diseases and Infection Control, University Hospital Regensburg, Regensburg, Germany.
  • Vehreschild MJGT; Department of Internal Medicine II, Division of Infectious Diseases, University Hospital Würzburg, Würzburg, Germany.
  • Römmele C; Department of Internal Medicine, Klinikum Dortmund, Dortmund, Germany.
  • Jung N; Department of Pharmacy, Städtisches Klinikum, Karlsruhe, Germany.
PLoS One ; 17(7): e0271822, 2022.
Article in English | MEDLINE | ID: covidwho-1968871
ABSTRACT

BACKGROUND:

COVID-19 is a severe disease with a high need for intensive care treatment and a high mortality rate in hospitalized patients. The objective of this study was to describe and compare the clinical characteristics and the management of patients dying with SARS-CoV-2 infection in the acute medical and intensive care setting.

METHODS:

Descriptive analysis of dying patients enrolled in the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS), a non-interventional cohort study, between March 18 and November 18, 2020. Symptoms, comorbidities and management of patients, including palliative care involvement, were compared between general ward and intensive care unit (ICU) by univariate analysis.

RESULTS:

580/4310 (13%) SARS-CoV-2 infected patients died. Among 580 patients 67% were treated on ICU and 33% on a general ward. The spectrum of comorbidities and symptoms was broad with more comorbidities (≥ four comorbidities 52% versus 25%) and a higher age distribution (>65 years 98% versus 70%) in patients on the general ward. 69% of patients were in an at least complicated phase at diagnosis of the SARS-CoV-2 infection with a higher proportion of patients in a critical phase or dying the day of diagnosis treated on ICU (36% versus 11%). While most patients admitted to ICU came from home (71%), patients treated on the general ward came likewise from home and nursing home (44% respectively) and were more frequently on palliative care before admission (29% versus 7%). A palliative care team was involved in dying patients in 15%. Personal contacts were limited but more often documented in patients treated on ICU (68% versus 47%).

CONCLUSION:

Patients dying with SARS-CoV-2 infection suffer from high symptom burden and often deteriorate early with a demand for ICU treatment. Therefor a demand for palliative care expertise with early involvement seems to exist.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0271822

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0271822